IIFL Group Utilizes CyberArk for Secure Developer Accessby Lilu Anderson 19.06.2024IIFL Group enhances developer cybersecurity and compliance with CyberArk, reducing risks and boosting operational efficiency.
Gold Prices Dip; Central Bank Purchases Could Boost Demandby Mark Eisenberg 19.06.2024Gold prices dipped amid limited Juneteenth trading. Central bank buying expected to boost demand despite fewer Fed rate cuts. Commodities ...
Keith Gill’s Return Sparks Volatility in GameStop Sharesby Mark Eisenberg 19.06.2024"Keith Gill's return and GameStop's 40% surge might signal stock market risk. Learn when to exit investments based on historical ...
US FDIC Chair Nominee Faces Potentially Delayed Confirmationby Mark Eisenberg 19.06.2024Christy Goldsmith Romero is expected to be confirmed as FDIC chair despite potential delays from Republican opposition and Senate procedural ...
Zilch Secures £100M, Gears Up for IPO Amid Rapid Growthby Mark Eisenberg 19.06.2024Zilch secures £100m from Deutsche Bank to triple sales and expand while considering an IPO potentially outside the UK amid ...
Nvidia’s Stock Target Raised by Stifel Amid Growth Prospectsby Mark Eisenberg 19.06.2024Nvidia’s growth in high-performance computing and AI drives Stifel to raise price target to $165. Risk factors include trade restrictions ...
Ethereum ETFs: SEC Hints July Launch, Investors Braceby John Darbie 19.06.2024SEC hints at potential July launch for spot Ethereum ETFs, with issuers facing a critical deadline this Friday to address ...
Katy Perry-Backed Bragg Explores Sale Amid Active Dealmakingby Mark Eisenberg 19.06.2024Bragg Live Food Products, famed for apple cider vinegar, explores a sale over $500M. Backed by Katy Perry and Orlando ...
Hashkey Launches BTC & ETH Futures with 10x Leverageby John Darbie 19.06.2024HashKey Global launches regulated Bitcoin & Ethereum futures trading with up to 10x leverage, following Bermuda Monetary Authority approval.
Trinity Biotech Stock Rated “Buy” Amid Price Fluctuationsby Lilu Anderson 19.06.2024Trinity Biotech plc gets a "buy" rating from StockNews.com analysts, spotlighting potential for investors with a focus on its diagnostic ...